For example, rhein inhibits colon cancer cell growth by targeting the mammalian target of rapamycin (mTOR) pathway and human kidney cancer cells through the mitogen-activated protein kinase (MAPK)/nuclear factor kappa-light-chain enhancer of activated B cells (NF-κB) signaling pathway [14,15]. This evidence concerns the gene MTOR and colonic neoplasm.